Breast Cancer Oncotype Testing
Value
£490,050
Suppliers
Classifications
- Pathology services
Tags
- award
Submission Deadline
8 months ago
Published
6 months ago
Description
Provision of Prognostic Genetic Testing for Breast Cancer Patients - to Improve availability of Oncotype DX to Breast cancer patients, reducing the need for post-operative chemotherapy. Additional information: Laboratory Diagnostics, Point of Care Testing and Pathology Managed Service 2023/S 000-028831,
Similar Contracts
AI Bid Assistant
Our AI-powered tool to help you create winning bids is coming soon!
Organisation
Timeline complete
Complete